"Patients diagnosed with headache may benefit from concurrent behavioral health evaluation and treatment," researchers said.

The Food and Drug Administration (FDA) has approved Symbravo ® (meloxicam/rizatriptan) for the acute treatment of migraine with or without aura in adults.

The Clinical Guidelines Committee of the American College of Physicians (ACP) has released a new clinical guideline on the ...

Panadol has unveiled sub-brand Panmigrol, aimed at tackling migraine pain.

Migraines affect millions worldwide, yet remain widely misunderstood. This neurological condition extends far beyond typical headache symptoms, often ...

A study published in The Lancet found that sodium nitrite provoked headaches in eight out of 13 people who consumed it.

Medical experts came together to address matters concerning the different types of headaches commonly experienced today.

A warning has been issued to anyone who eats bananas or cheese, as these foods can trigger nasty migraines. Migraines feel ...

FDA approves Symbravo for acute migraine relief, combining rizatriptan and meloxicam. Discover its unique benefits and fast absorption for effective symptom control.

The harrowing final messages of 25-year-old DJ Alex Theodossiadis before he died from meningitis have been revealed by his ...

The novel formulation of rizatriptan and meloxicam (Symbravo, Axome Therapeutics) is for the acute treatment of migraine with ...

The global prevalence and incidence of migraine significantly increased from 1990 to 2021, with faster growth rates predicted in men and adolescents through 2050.